<DOC>
	<DOCNO>NCT01992263</DOCNO>
	<brief_summary>The goal study understand effect vitamin D supplementation immunological outcome among patient tuberculosis .</brief_summary>
	<brief_title>Vitamin D Supplementation TB</brief_title>
	<detailed_description>In randomized trial , investigator enroll 200 adult active pulmonary tuberculosis ( TB ; among 40 HIV co-infections ) time TB diagnosis S India . The intervention include daily vitamin D supplementation 3 treatment arm ( 600 , 2000 , 4000 IU vitamin D ) , compare placebo , 12 month . The investigator ' primary objective assess vitamin D supplementation affect immunity ( immunological marker , immune competence ) serum vitamin D level . Secondary outcome include TB treatment outcome ( successful sputum smear conversion , relapse ) patient , human immunodeficiency virus ( HIV ) disease progression among subset patient HIV co-infection .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Active TB diagnosis GeneXpert HIV infection status ( accord AMC HIV clinic medical record enzymelinked immunosorbent assay [ ELISA ] result ) Children ( &lt; 18 year age ) 60 year age Pregnant baseline Other severe complication illness require hospitalization Received TB treatment great 4 week past 5 year Refused participate Residing geographic location &gt; 1 hour AMC ( public transit )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>vitamin D</keyword>
	<keyword>immunity</keyword>
</DOC>